Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

817
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
817
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

666
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
666
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

3.4K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.4K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

295
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
295
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

306
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
306
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

3.2K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ki67 dynamic predicts endocrine sensitivity in estrogen receptor-positive/HER2-negative breast cancer patients undergoing preoperative endocrine therapy.

ESMO open·2025
Same author

Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial.

ESMO open·2025
Same author

Cardiovascular risk of gender-affirming estrogen therapy in a transgender rat model.

Journal of molecular medicine (Berlin, Germany)·2025
Same author

Prevalence and clinical impact of germline pathogenic variants in breast cancer: a descriptive large single-center study.

ESMO open·2025
Same author

Keratinocyte-derived extracellular vesicles induce macrophage polarization toward an M1-like phenotype.

Biochemical and biophysical research communications·2025
Same author

Analytical validation of HER2DX genomic test for early-stage HER2-positive breast cancer.

ESMO open·2024

Related Experiment Video

Updated: Dec 25, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.9K

Acute, subacute and chronic mountain sickness.

E Garrido1, J Botella de Maglia2, O Castillo3

  • 1Servicio de Hipobaria y Fisiología Biomédica, Universidad de Barcelona, L'Hospitalet de Llobregat, Barcelona, España; Instituto de Estudios de Medicina de Montaña (IEMM), Barcelona, España.

Revista Clinica Espanola
|March 22, 2020
PubMed
Summary
This summary is machine-generated.

Millions ascend to high altitudes annually, facing risks of acute mountain sickness, high-altitude pulmonary hypertension, and Monge's disease. Early recognition and management are crucial for preventing severe outcomes in these challenging environments.

Keywords:
AltitudAltitudeEnfermedad de MongeHipertensión pulmonarHipoxiaHypoxiaMal de montañaMonge's diseaseMontañismoMountain sicknessMountaineeringPulmonary hypertension

More Related Videos

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
04:24

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease

Published on: September 5, 2025

671
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

1.3K

Related Experiment Videos

Last Updated: Dec 25, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.9K
Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
04:24

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease

Published on: September 5, 2025

671
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

1.3K

Area of Science:

  • Physiology
  • Environmental Medicine
  • Altitude Sickness Research

Background:

  • Over 100 million people annually travel to high altitudes (>2500m).
  • 10-85% experience acute mountain sickness (AMS) at <5500m due to hypobaric hypoxia.
  • 140 million reside permanently at high altitudes, with up to 10% developing subacute (high-altitude pulmonary hypertension) or chronic (Monge's disease) forms.

Purpose of the Study:

  • To review the general concepts of AMS, high-altitude pulmonary hypertension, and Monge's disease.
  • To highlight the potential for incapacitation and life-threatening complications.
  • To emphasize the importance of prevention, diagnosis, and management strategies.

Main Methods:

  • Literature review of existing research on altitude-related illnesses.
  • Synthesis of clinical concepts for three distinct high-altitude syndromes.
  • Focus on pathophysiology, clinical presentation, and management.

Main Results:

  • Acute mountain sickness affects a significant percentage of travelers.
  • Chronic forms like Monge's disease disproportionately affect high-altitude residents, particularly in Andean populations.
  • These conditions can range from mild to life-threatening.

Conclusions:

  • Altitude sickness encompasses a spectrum of conditions, including AMS, high-altitude pulmonary hypertension, and Monge's disease.
  • Effective prevention, accurate diagnosis, and timely treatment are vital for managing these illnesses.
  • Understanding these syndromes is essential for healthcare in high-mountain environments.